Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis

Surg Today. 2008;38(2):130-4. doi: 10.1007/s00595-007-3586-5. Epub 2008 Feb 1.

Abstract

Purpose: Elevated plasma A-type natriuretic peptide (ANP) levels in sepsis cause fluid transfer into extravascular spaces. We investigated the changes in ANP concentrations and natriuretic peptide receptor (NPR) expression induced by thiorphan, a neutral endopeptidase (NEP) inhibitor, in a rat model of sepsis.

Methods: Fifteen male rats were divided into three groups: a control group (n = 5), a lipopolysaccharide (LPS) group (n = 5), and an LPS-thiorphan group (n = 5). We measured ANP concentrations in the plasma and lung, and NPR mRNA expression in the lung 4 h after administering LPS, and compared the values with those in the control group.

Results: Plasma and lung ANP levels in the LPS group were significantly higher than those in the control group (P < 0.05), but were significantly decreased by thiorphan administration (P < 0.05). NPR-A mRNA levels did not differ significantly among the groups. NPR-C mRNA levels in the LPS-thiorphan group were significantly higher than those in the other groups (P < 0.05).

Conclusions: Elevated ANP levels were decreased by thiorphan administration, which increased NPR-C mRNA levels in the lung. Thus, thiorphan might be effective for reducing elevated ANP levels in sepsis.

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / analysis
  • Atrial Natriuretic Factor / blood*
  • Disease Models, Animal
  • Lung / chemistry
  • Lung / drug effects*
  • Male
  • Protease Inhibitors / pharmacology
  • Rats
  • Receptors, Atrial Natriuretic Factor / analysis*
  • Sepsis / blood*
  • Sepsis / physiopathology
  • Thiorphan / pharmacology

Substances

  • Protease Inhibitors
  • Atrial Natriuretic Factor
  • Thiorphan
  • Receptors, Atrial Natriuretic Factor